Understanding Coronavirus

2. Revised Auflage 2021
ISBN: 978-1-316-51486-3
Verlag: Cambridge University Press

Buch, Englisch, 175 Seiten, Format (B × H): 203 mm x 185 mm, Gewicht: 227 g

Reihe: Understanding Life

Since the identification of the first cases of the coronavirus in December 2019, there has been a significant amount of confusion regarding the origin and spread of the so-called 'coronavirus', SARS-CoV-2, and the cause of the disease COVID-19. Conflicting messages from the media and officials across different countries and organizations, the abundance of disparate sources of information, unfounded conspiracy theories on the origins of the virus, unproven therapies, and inconsistent public health measures, have all served to increase anxiety in the population. Where did the virus come from? How is it transmitted? How does it cause disease? Is it like flu? What is a pandemic? In this concise and accessible introduction, a leading expert provides answers to these commonly asked questions. This revised and updated edition now also covers how the virus mutates, how important these mutations are, how vaccines work, and what we can expect in the near and long-term future.

Autoren/Hrsg.

Rabadan, Raul

Fachgebiete

• Naturwissenschaften Biowissenschaften Mikrobiologie

Inhaltsverzeichnis

Preface; 1. Introduction; 2. How Is the Coronavirus Spreading?; 3. What Is a Coronavirus?; 4. How Is the Coronavirus Changing?; 5. How Did the COVID-19 Outbreak Start and Evolve?; 6. How Does the COVID-19 Outbreak Compare to the SARS Outbreak in 2003?; 7. How Does the COVID-19 Outbreak Compare to Seasonal and Pandemic Influenza?; 8. How Can We Treat the Virus and Prevent Infections?; Conclusions; Summary of Common Misunderstandings; Suggested Further Reading.

Über Autor(innen)

Rabadan, Raul
Raul Rabadan is a Professor in the Departments of Systems Biology and Biomedical Informatics, and the Director of the Program for Mathematical Genomics, at Columbia University. From 2001 to 2003, Dr. Rabadan was a fellow at the Theoretical Physics Division at CERN, the European Organization for Nuclear Research, in Geneva, Switzerland. In 2003 he joined the School of Natural Sciences at the Institute for Advanced Study in Princeton, New Jersey. He has been named one of Popular Science's Brilliant 10 (2010), a Stewart Trust Fellow (2013), and has received the Harold and Golden Lamport (2014), Diz Pintado (2018) and Phillip Sharp (2018) awards. Dr. Rabadan's current interest focuses on uncovering patterns of evolution in biological systems - in particular, RNA viruses and cancer. Dr. Rabadan is the founder of Genotwin, a data-driven genomic company.